harvard pilgrim health care glp 1 coverage Pilgrim, Tufts Plan CEO talks GLP-1 weight-loss drug HEALTH INSURANCE PLANS - Health,

Control Release 266 , 100108 (2017)

Guan B, Tong J, Hao H, Yang Z, Chen K, Xu H, et al

This extended half-life supports long-lasting effects, making it a convenient option for patients who struggle with daily medication regimens

Acute and sustained GLP-1 receptor signalling leads to reduction in appetite and food intake leading to subsequent weight loss [14, 15]

Maybe just a few units every injection

In two breast cancer studies, GLP1R agonism suppressed the production of pro-inflammatory cytokines (IL-8, VEGF) and promoted accumulation of CD8+ cytotoxic T-cells within the primary tumor, resulting in decreased proliferation and delayed tumor growth (76, 77)